What should you know about William Coley immunotherapy?

William Coley was a physician associated with the historical observation that an intense infection sometimes coincided with a change in a tumour. He developed bacterial preparations, often called Coley's toxins, in an attempt to trigger a strong immune reaction. The preparations were not standardised in the way current cancer medicines are, and the approach could cause serious systemic illness.

The idea helped shape the broader concept that the immune system can influence cancer. Modern immunotherapy is different: medicines are manufactured and tested for defined uses, and may help immune cells recognise or attack cancer through specific pathways. A historical account of Coley's work should not be taken as advice to use bacterial products or induce infection.

If you are considering immunotherapy, discuss the diagnosis, treatment goal, approved options, and eligibility criteria with an oncology team. Ask how the proposed medicine works, how it will be monitored, and whether a clinical-trial discussion is relevant. Do not self-treat with bacteria, toxins, supplements, or deliberate infection; these can delay care and cause harm.

During any immune-based cancer treatment, report new breathing difficulty, severe diarrhoea, persistent vomiting, yellowing of the skin, marked rash, confusion, or extreme weakness promptly. Immune reactions can affect organs and may need treatment quickly. Fever or signs of infection also need timely medical advice.

Ask whether modern immunotherapy has a role for your cancer, what evidence supports the proposed treatment, which immune-related effects to watch for, and who to contact outside clinic hours.